Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of success rate of radioiodine therapy protocols for Graves' disease
TCTR20240831001Phase 3Completed
- Sponsor
- Burapha University
- Start
- Jan 2014
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
A Phase 3 trial of iodine-131 in Graves' disease, sponsored by Burapha University. Started Jan 2014; status: completed.
02
Drugs
iodine-131
03
Conditions
Graves' disease
Beyond the preview
Go deeper on TCTR20240831001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240831001.